Matches in SemOpenAlex for { <https://semopenalex.org/work/W2070097037> ?p ?o ?g. }
Showing items 1 to 97 of
97
with 100 items per page.
- W2070097037 endingPage "1234" @default.
- W2070097037 startingPage "1228" @default.
- W2070097037 abstract "PurposeOur purpose was to characterize the occurrence of gastrointestinal (GI) events among women on oral bisphosphonate therapy.MethodsThis was a retrospective cohort study that used a United States (US) claims database. The study period was from January 1, 2000, to December 31, 2011. The index date was the date of the first oral bisphosphonate (alendronate, ibandronate, or risedronate) prescription and occurred between January 1, 2001, and December 31, 2010. The pre- and post-index periods were the 1-year periods before and after the index date, respectively. The analysis included women with osteoporosis aged ≥55 years at the index date who were naive to all osteoporosis treatments before the index date and were continuously enrolled in the health plan for at least 1 year before and 1 year after the index date. Patients with a diagnosis of malignant neoplasm during the pre- or post-index periods or a diagnosis of Paget disease anytime in the claims history were excluded. The occurrence of GI events (defined as esophagitis; gastroesophageal reflux disease; ulcer, stricture, perforation, or hemorrhage of the esophagus; gastric, duodenal, or peptic ulcer; acute gastritis; duodenitis; GI hemorrhage; nausea/vomiting; or dysphagia) was assessed during the pre-index period and at 3, 6, and 12 months in the post-index period. The rate of GI events was defined as the percentage of patients having at least 1 GI event in each analysis period (ie, pre-index and post-index periods). GI events in the post-index period were also stratified by the presence of GI events in the pre-index period.FindingsA total of 75,593 women were included in the analysis. The average age at the index date was 64.4 years. Gastroprotective agents were used by 17.9% of patients. Approximately one fourth of patients (26.6%; n = 20,073) had ≥1 GI events in the pre-index period. Approximately the same proportion of patients (28.0%; n = 21,142) experienced GI events in the post-index period. The cumulative rate of GI events during the post-index period was higher among patients who had GI events in the pre-index period (51.2%) than among patients without a GI event in the pre-index period (19.6%).ImplicationsAmong women with osteoporosis enrolled in a US commercial plan, GI events were common regardless of bisphosphonate use. Approximately one fourth of US women on bisphosphonate therapy experienced GI events within the year after initiation of therapy, and one half of US women with a previous GI event had another event while taking bisphosphonates." @default.
- W2070097037 created "2016-06-24" @default.
- W2070097037 creator A5035037835 @default.
- W2070097037 creator A5036509509 @default.
- W2070097037 creator A5053213573 @default.
- W2070097037 creator A5082138574 @default.
- W2070097037 date "2015-06-01" @default.
- W2070097037 modified "2023-10-16" @default.
- W2070097037 title "Gastrointestinal Events Among Patients Initiating Osteoporosis Therapy: A Retrospective Administrative Claims Database Analysis" @default.
- W2070097037 cites W1492812147 @default.
- W2070097037 cites W1606867770 @default.
- W2070097037 cites W190001218 @default.
- W2070097037 cites W1964692065 @default.
- W2070097037 cites W1972185253 @default.
- W2070097037 cites W1992158817 @default.
- W2070097037 cites W1994835085 @default.
- W2070097037 cites W2053937069 @default.
- W2070097037 cites W2068663733 @default.
- W2070097037 cites W2072952498 @default.
- W2070097037 cites W2076649502 @default.
- W2070097037 cites W2082875779 @default.
- W2070097037 cites W2086947316 @default.
- W2070097037 cites W2097206106 @default.
- W2070097037 cites W2106398927 @default.
- W2070097037 cites W2107544704 @default.
- W2070097037 cites W2107947802 @default.
- W2070097037 cites W2129168200 @default.
- W2070097037 cites W2131056136 @default.
- W2070097037 cites W2133029180 @default.
- W2070097037 cites W2141926703 @default.
- W2070097037 cites W2168113037 @default.
- W2070097037 cites W24657202 @default.
- W2070097037 cites W4211100531 @default.
- W2070097037 doi "https://doi.org/10.1016/j.clinthera.2015.03.018" @default.
- W2070097037 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25866298" @default.
- W2070097037 hasPublicationYear "2015" @default.
- W2070097037 type Work @default.
- W2070097037 sameAs 2070097037 @default.
- W2070097037 citedByCount "12" @default.
- W2070097037 countsByYear W20700970372015 @default.
- W2070097037 countsByYear W20700970372016 @default.
- W2070097037 countsByYear W20700970372017 @default.
- W2070097037 countsByYear W20700970372018 @default.
- W2070097037 countsByYear W20700970372019 @default.
- W2070097037 countsByYear W20700970372021 @default.
- W2070097037 countsByYear W20700970372022 @default.
- W2070097037 countsByYear W20700970372023 @default.
- W2070097037 crossrefType "journal-article" @default.
- W2070097037 hasAuthorship W2070097037A5035037835 @default.
- W2070097037 hasAuthorship W2070097037A5036509509 @default.
- W2070097037 hasAuthorship W2070097037A5053213573 @default.
- W2070097037 hasAuthorship W2070097037A5082138574 @default.
- W2070097037 hasBestOaLocation W20700970371 @default.
- W2070097037 hasConcept C126322002 @default.
- W2070097037 hasConcept C141071460 @default.
- W2070097037 hasConcept C167135981 @default.
- W2070097037 hasConcept C191897082 @default.
- W2070097037 hasConcept C192562407 @default.
- W2070097037 hasConcept C2776541429 @default.
- W2070097037 hasConcept C2778456384 @default.
- W2070097037 hasConcept C2778527123 @default.
- W2070097037 hasConcept C2780596822 @default.
- W2070097037 hasConcept C2780852908 @default.
- W2070097037 hasConcept C71924100 @default.
- W2070097037 hasConceptScore W2070097037C126322002 @default.
- W2070097037 hasConceptScore W2070097037C141071460 @default.
- W2070097037 hasConceptScore W2070097037C167135981 @default.
- W2070097037 hasConceptScore W2070097037C191897082 @default.
- W2070097037 hasConceptScore W2070097037C192562407 @default.
- W2070097037 hasConceptScore W2070097037C2776541429 @default.
- W2070097037 hasConceptScore W2070097037C2778456384 @default.
- W2070097037 hasConceptScore W2070097037C2778527123 @default.
- W2070097037 hasConceptScore W2070097037C2780596822 @default.
- W2070097037 hasConceptScore W2070097037C2780852908 @default.
- W2070097037 hasConceptScore W2070097037C71924100 @default.
- W2070097037 hasIssue "6" @default.
- W2070097037 hasLocation W20700970371 @default.
- W2070097037 hasLocation W20700970372 @default.
- W2070097037 hasOpenAccess W2070097037 @default.
- W2070097037 hasPrimaryLocation W20700970371 @default.
- W2070097037 hasRelatedWork W1992138464 @default.
- W2070097037 hasRelatedWork W1998848462 @default.
- W2070097037 hasRelatedWork W2164373547 @default.
- W2070097037 hasRelatedWork W2352348542 @default.
- W2070097037 hasRelatedWork W2383166333 @default.
- W2070097037 hasRelatedWork W2559941419 @default.
- W2070097037 hasRelatedWork W2774680161 @default.
- W2070097037 hasRelatedWork W2895036280 @default.
- W2070097037 hasRelatedWork W3082763462 @default.
- W2070097037 hasRelatedWork W2188213098 @default.
- W2070097037 hasVolume "37" @default.
- W2070097037 isParatext "false" @default.
- W2070097037 isRetracted "false" @default.
- W2070097037 magId "2070097037" @default.
- W2070097037 workType "article" @default.